Related Experiment Video
Updated: May 14, 2026
09:51
Development and Functional Characterization of Murine Tolerogenic Dendritic Cells
Published on: May 18, 2018
Human tolerogenic DC-10: perspectives for clinical applications
1San Raffaele Telethon Institute for Gene Therapy (OSR-TIGET), Division of Regenerative Medicine, Stem Cells and Gene Therapy, San Raffaele Scientific Institute, Via Olgettina, 58, 20132, Milan, Italy. gregori.silvia@hsr.it.
Transplantation Research
|February 2, 2013
Summary
Interleukin-10 (IL-10) differentiates tolerogenic dendritic cells (DCs), known as DC-10. These cells induce regulatory T cells to promote immune tolerance, offering therapeutic potential for T-cell-mediated diseases.
Area of Science:
- Immunology
- Cell Biology
- Translational Medicine
Background:
- Dendritic cells (DCs) play a crucial role in immune responses, dictating either immunity or tolerance.
- Developing methods to manipulate DCs in vitro for enhanced tolerogenic properties is an active research area.
- Interleukin-10 (IL-10) is a key cytokine in immune regulation.
Purpose of the Study:
- To review and compare the phenotype and suppressive mechanisms of DC-10 with other regulatory antigen-presenting cells.
- To discuss the therapeutic applications of DC-10 in cell-based therapies for immune tolerance.
- To highlight the potential of DC-10 in treating T-cell-mediated diseases.
Main Methods:
- In vitro differentiation of monocyte-derived DCs with IL-10 to generate DC-10.
- Phenotypic characterization of DC-10, focusing on IL-10/IL-12 ratio, HLA-G, and immunoglobulin-like transcript 4 (ILT4) expression.
- Comparison of DC-10 with other regulatory antigen-presenting cells (APCs) in preclinical and clinical development.
Main Results:
- DC-10 exhibit a distinct tolerogenic phenotype characterized by a high IL-10/IL-12 ratio and co-expression of HLA-G and ILT4.
- DC-10 are potent inducers of adaptive type 1 regulatory T cells (Tr1 cells).
- Tr1 cells are crucial for establishing and maintaining peripheral tolerance.
Conclusions:
- DC-10 represent a promising subset of human tolerogenic DCs with significant therapeutic potential.
- DC-10 can be utilized for tailoring regulatory T-cell-based therapies.
- Adoptive DC-10 therapy offers a strategy for promoting and restoring tolerance in T-cell-mediated diseases.
